HR467: HALT Fentanyl Act
118th Congress (2023–2025) · House bill · Sponsor: Rep. Griffith, H. Morgan [R-VA-9]
This page covers HR467 in the 118th Congress. Bill numbers start over every Congress, so HR467 in another Congress is a different bill.

118th Congress (2023–2025) · House bill · Sponsor: Rep. Griffith, H. Morgan [R-VA-9]
This page covers HR467 in the 118th Congress. Bill numbers start over every Congress, so HR467 in another Congress is a different bill.
| Item | Detail |
|---|---|
| Roll-call votes | 1 |
| Chamber | House |
| Latest vote | 2023-05-25: Passed |
| Latest action | 2023-05-30: Received in the Senate and Read twice and referred to the Committee on the Judiciary. |
| Policy area | Crime and Law Enforcement |
| Official record | Congress.gov |
Halt All Lethal Trafficking of Fentanyl Act or the HALT Fentanyl Act This bill permanently places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act. (The temporary scheduling order issued by the Drug Enforcement Administration to place fentanyl-related substances into schedule I of the Controlled Substances Act expires on December 31, 2024.) Under the bill, offenses involving fentanyl-related substances are triggered by the same quantity thresholds and subject to the same penalties as offenses involving fentanyl analogues (e.g., offenses involving 100 grams or more trigger a 10-year mandatory minimum prison term). Additionally, the bill establishes a new, alternative registration process for schedule I research that is funded by the Department of Health and Human Services or the Department of Veterans Affairs or that is conducted under an investigative new drug exemption from the Food and Drug Administration. The bill also makes several other changes to registration requirements for conducting research with controlled substances, including permitting a single registration for related research sites in certain circumstances, waiving the requirement for a new inspection in certain situations, and allowing a registered researcher to perform certain manufacturing activities…
Subjects: Administrative law and regulatory procedures, Department of Justice, Drug trafficking and controlled substances, Licensing and registrations, Research administration and funding
Every recorded vote on this bill, newest first, with a link to the official tally. Member-by-member positions are on each member’s profile.
| Date | Chamber | Question | Result | Yea | Nay | Not voting | Record |
|---|---|---|---|---|---|---|---|
| 2023-05-25 | House | Yea-and-Nay | Passed | 236 | 118 | 9 | Official tally |
HR467 (HALT Fentanyl Act) was introduced in the 118th Congress (2023–2025) by Rep. Griffith, H. Morgan [R-VA-9].
On 2023-05-30: Received in the Senate and Read twice and referred to the Committee on the Judiciary.
1 recorded vote in the 118th Congress. The most recent, on 2023-05-25, was "Yea-and-Nay": Passed.